Life Sciences Digital Services 2020-2021 RadarView™

April, 2020


Report Summary

Scope of the Report

The report covers the global life sciences industry (including pharmaceutical, medical device, and biotechnology companies), the ecosystem participants and their interplay, key challenges, technology landscape with particular emphasis on digital levers, regulatory developments, patient-related trends, M&A and partnerships, critical case studies, and outsourcing engagements.
It also provides a fact-based detailed assessment of leading 18 service providers enabling digital transformation for life sciences companies. The profiles for each of these 18 providers capture their practice (or business unit) overview, industry-specific solutions and offerings, key clients, partnerships, capabilities across the value chain, case studies, and analyst insights on their practice maturity, investments & innovations, and partner ecosystem, thus providing a 360-degree view of service providers.

Why read this RadarView™ ?

The life sciences industry is under constant scrutiny from regulatory associations and governments regarding the quality and prices of drugs and therapies, patient welfare, and security of patient data. These pressures, along with the rise of chronic diseases, are pushing companies towards alternate product lines and personalization of therapies for cost containment and enhanced patient engagement. Avasant’s ongoing interactions with industry leaders indicate that the integration of digital technologies in processes across the value chain will foster innovative approaches for discovery, development, and launch of cost-effective therapies. Enterprises need to channel investments towards these business outcomes and partner with service providers that can accelerate their digital transformation journey. The report also highlights the key trends in the market and Avasant’s view on the road ahead for life sciences companies over the next three years. It provides information to assist enterprises in charting out their action plan and identifies key global service providers and system integrators that can expedite their transformation.

LifeSciences2020Moneyshot 1030x687 - Life Sciences Digital Services 2020-2021 RadarView™


Featured Providers

Accenture, Atos, Birlasoft, Capgemini, CGI, Cognizant, DXC, Genpact, HCL, Hexaware, IBM, Infosys, LTI, Mphasis, NTT DATA, TCS, Tech Mahindra, and Wipro.


The industry insights and recommendations are based on Avasant’s ongoing interactions with enterprise CXOs and other key executives, targeted discussions with service providers’ practice leads, subject matter experts and fellows within Avasant, learnings from consulting engagements, and round the year tracking of this space by Avasant analysts.

Evaluation of service providers is based on primary inputs from providers, focussed briefings, their public disclosures, Avasant’s ongoing market interactions, and validations from enterprises (clients). The assessment is carried through a rigorous methodology across critical dimensions of Practice Maturity, Partner Ecosystem, and Investments and Innovation to finally recognize the service providers that brought the most value to the market over the last 12 months.

Click here to access the Research Byte based on this report.